This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Community News - April 26, 2018
Share |

 

CASSS COMMUNITY NEWS HOME

 


View the Abstracts for the 8 May Netherlands Area Biotech Discussion Group on Prior Knowledge

The next NLab Discussion Group will take place at LUMC in Leiden on 8 May 2018. Speakers include:

Using Prior Knowledge in Development of Adenovirus Vector-Based Vaccines
Marta Germano,Janssen R&D

Summary of the 2017 EMA Workshop on Prior Knowledge and Its Use in Regulatory Applications
Ronald Imhoff,Janssen Biologics

Case Study of Prior Knowledge: Development and Implementation of a Binding Assay to Assess the Potency of Synagis® (palivizumab)
Mark Schenerman,CMC Biotech-MAS Consulting

Don't miss this opportunity for discussion and networking with peers; complimentary registration is available until 3 May!


Speakers and Talk Titles Announced for CE Pharm and Mass Spec 2018: Don't Miss This Amazing Lineup! 


(CE-SHS): A Novel Approach to Characterizing the Purity of Certain Therapeutic Protiens

Jeff Beckman, Bristol-Myers Squibb Company

Monitoring Glycosylation Profile and Protein Titer in Cell Culture Samples
Using ZipChip CE-MS


Yan Wang, Biogen

Using CE-SDS-LIF and CE-MS to
Characterize Enzyme Induced Degradation
of Protein Therapeutics


Yunan Wang, Amgen Inc

VIEW THE FULL LIST OF CE PHARM SPEAKERS
AND TALK TITLES

 



Heightened Characterization of ADCs: OvercomingChallenges to Support
Process and Product Understanding

Olga Friese, Pfizer, Inc.


Quantitative Analysis of Glycation and Its
Impact on Antigen Binding

Jingjie Mo, Janssen R&D, LLC

Mass Spectrometry in the
CAR-T Development Lab

Ken Prentice, Juno Therapeutics

 

VIEW THE FULL LIST OF MASS SPEC SPEAKERS
AND TALK TITLES


Interested in speaking at one of these meetings? Take the opportunity to be in the oral program and share your success, pain points and knowledge.
SUBMIT AN ABSTRACT
FOR CE PHARM

SUBMIT AN ABSTRACT
FOR MASS SPEC

Registration is open for Cell & Gene Therapy Products (CGTP): Manufacturing, Quality and Regulatory Considerations

The success of the 2017 Summer CMC Forum, focused on cell and gene therapies, demonstrated the benefit and need to provide an ongoing open forum for dialogue and exchange of scientific and technical advances that are the basis of evolving regulatory practices for this diverse array of innovative products.

Last year's Summer CMC Forum attendance included:

Join CASSS at CGTP as we striveto explore all of this in an open and transparent format with regulatory, industry and academic professionals.



Other than eight full time staff, CASSS is entirely run by volunteers and governed by a twelve-member volunteer Board of Directors who are elected by the Associate Directors.

Who are the Associate Directors, and what are their responsibilities?

Who organizes the CASSS meetings and chooses the topics?

Who are the full time staff?

You can learn all about CASSS leadership on the website!


Upcoming CASSS Meetings


REGISTER NOW AND SAVE

MAKE YOUR HOTEL RESERVATIONS

SUBMIT AN ABSTRACT

APPLY FOR A STUDENT TRAVEL GRANT




 
 

 



 


more Calendar

1/28/2019 » 1/31/2019
CMC Strategy Forum and WCBP 2019

1/29/2019 » 1/31/2019
WCBP 2019 Live Stream

3/12/2019 » 3/13/2019
CMC Strategy Forum Latin America 2019

Featured Members
William Weiss, Eli Lilly and CompanyFind out more about Will in this month's Member Spotlight!

Membership Software Powered by YourMembership  ::  Legal